Skip to content
ReagentPolymedco

BTA stat® Test

Rapid, non-invasive bladder cancer surveillance aid

A rapid point-of-care immunoassay that detects a bladder tumor-associated protein in urine, intended as an aid in the surveillance of patients with a history of bladder cancer.

BTA stat® Test
Overview

The BTA stat® Test from Polymedco is a rapid, point-of-care immunoassay that detects a bladder tumor-associated protein (human complement factor H-related protein) in a voided urine sample. It is intended as an aid in the management of patients with a history of bladder cancer, used together with cystoscopy and other established clinical assessments.

Because the test is performed directly from a urine sample, it offers a simple, non-invasive step within routine follow-up. The qualitative result is read quickly, which can make it convenient to incorporate into outpatient urology and oncology workflows. It is intended to complement, not replace, cystoscopic surveillance.

Polymedco specializes in bladder cancer testing, and the BTA stat® Test is part of that focus. Through Biostate DX, the assay is made available to laboratories, clinics and urology practices in India as part of a patient-centered diagnostic portfolio.

Applications
Aiding routine surveillance of patients with a history of bladder cancerNon-invasive testing during follow-up after treatment, alongside cystoscopyPoint-of-care assessment in outpatient urology clinicsSupporting clinical assessment in oncology and urology workflowsUrine-based testing where patient comfort and a rapid result are priorities
Key highlights
  • Detects a bladder tumor-associated protein directly in a voided urine sample
  • Non-invasive and simple to perform at the point of care
  • Rapid qualitative result that fits into routine follow-up workflows
  • Intended as an aid in the management of patients with a history of bladder cancer
  • Designed to be used alongside cystoscopy and other clinical assessments
  • Manufactured by Polymedco, a company focused on bladder cancer testing
  • Suited to outpatient urology, oncology and laboratory settings
  • Available in India through Biostate DX
Specifications

At a glance

Test type
Rapid point-of-care immunoassay
Analyte detected
Bladder tumor-associated protein (human complement factor H-related protein)
Sample type
Voided urine
Result format
Qualitative, rapid read-out
Intended use
Aid in the management of patients with a history of bladder cancer
Procedure
Non-invasive, simple to perform
Setting
Point of care / outpatient and laboratory use
Manufacturer
Polymedco (USA)

Specifications are indicative and provided for general guidance. Exact configurations, claims and regulatory status vary by model and region — contact us for the current datasheet.

Enquire

Interested in BTA stat® Test?

Request pricing, a datasheet or a hands-on demonstration. Our specialists will tailor a recommendation to your laboratory's workflow and volumes.

Submitting opens WhatsApp with your details pre-filled — just press send to reach our team.